Analytics
New International Collaboration: VRG Therapeutics Awarded Grant for Biased Drug Discovery Research

We are excited to announce that we have successfully secured funding for a novel collaborative project "Mapping AT1R Conformations for Biased Drug Discovery" under the 2025‑1.2.3‑TÉT‑IPARI‑KR grant.

The project is a joint effort with: • Dr. Gabor Turu from the Cellular Physiology Research Group at the Institute of Molecular Life Sciences, HUN‑REN Research Centre for Natural Sciences. • and Professor Ka Young Chung from the School of Pharmacy, Sungkyunkwan University (South Korea).

This grant will extend our capabilities in targeting different GPCR receptor conformations and in unlocking cryptic protein domains. We're absolutely thrilled about this global collaboration and look forward to pioneering approaches to create new classes of therapeutic compounds. A big thank to all our partners and supporters — the journey ahead is full of exciting possibilities!Stay tuned for more updates, and feel free to reach out for collaboration or inquiries.

Stay tuned for more updates, and feel free to reach out for collaboration or inquiries.

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
January 18, 2026
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
January 18, 2026
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Conference
January 28, 2026
By VRG Therapeutics
2026 International Roadshow Begins
White arrow icon up and right direction redirecting to Partner with US page
VRG-145
January 18, 2026
By VRG Therapeutics
Novamigra Therapeutics Secures- Funding-First-in-Human Study of Migraine Prophylaxis Asset VRG-145
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Conference
January 28, 2026
By VRG Therapeutics
2026 International Roadshow Begins
White arrow icon up and right direction redirecting to Partner with US page
VRG-145
January 18, 2026
By VRG Therapeutics
Novamigra Therapeutics Secures- Funding-First-in-Human Study of Migraine Prophylaxis Asset VRG-145
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life